Regulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats
- 5 October 2005
- journal article
- research article
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 125 (3) , 215-225
Abstract
Simon extracts are vitamin K1-rich food materials extracted from the leaves of the Simon sweet potato. Although vitamin K is known to stimulate bone formation, we postulated that Simon extracts also contain unknown biological compounds having the ability to regulate bone resorption. Here we prepared the vitamin K-free fraction from the Simon extracts and investigated the ability of this fraction on the differentiation of osteoclasts. A remarkable inhibitory effect of osteoclastogenesis was observed when osteoclast precursors were treated with this fraction in rat bone marrow culture systems as well as in a pure differentiation system using murine osteoclast precursor cell line. The vitamin K-free Simon extracts markedly suppressed severe bone destruction mediated by abundant osteoclasts associated with adjuvant-induced arthritis in rats. High performance liquid chromatography (HPLC) analysis revealed that the vitamin K-free Simon extracts contained three types of low molecular weight inhibitors for osteoclastogenesis; caffeic acid, chlorogenic acids and isochlorogenic acids. Among these substances, caffeic acid showed the most powerful inhibitory effects on osteoclastogenesis. Caffeic acid significantly suppressed expression of NFATc1, a key transcription factor for the induction of osteoclastogenesis. Our current study enlightened a high utility of the Simon extracts and their chemical components as effective regulators for bone resorption accompanied with inflammation and metabolic bone diseases.Keywords
This publication has 40 references indexed in Scilit:
- Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXRJournal of Biological Chemistry, 2003
- Genetic regulation of osteoclast development and functionNature Reviews Genetics, 2003
- Osteoclastogenesis, Bone Resorption, and Osteoclast-Based TherapeuticsJournal of Bone and Mineral Research, 2003
- Osteoporosis in childhood rheumatic diseases: prevention and therapyBest Practice & Research Clinical Rheumatology, 2002
- Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritisBone, 2002
- Therapeutic Approaches to Bone DiseasesScience, 2000
- Caffeic Acid Phenethyl Ester Induces Leukocyte Apoptosis, Modulates Nuclear Factor-Kappa B and Suppresses Acute InflammationNeuroimmunomodulation, 1999
- Activation of NF-κB Is Involved in the Survival of Osteoclasts Promoted by Interleukin-1Journal of Biological Chemistry, 1998
- c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone RemodelingScience, 1994
- Induction of Mononuclear Precursor Cells with Osteoclastic Phenotypes in a Rat Bone Marrow Culture System Depleted of Stromal CellsBiochemical and Biophysical Research Communications, 1993